{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05742867",
            "orgStudyIdInfo": {
                "id": "CA209-6M4"
            },
            "organization": {
                "fullName": "Bristol-Myers Squibb",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder",
            "officialTitle": "Patient Preferences of Treatment for the Patients Suffering From Muscle-invasive Urothelial Carcinoma of Bladder Following Radical Cystectomy in Japan",
            "acronym": "SNUGGLE",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-to-evaluate-treatment-preferences-for-japanese-participants-with-muscle-invasive-urothelial-carcinoma-of-the-bladder"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-31",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-28",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-01",
            "studyFirstSubmitQcDate": "2023-02-14",
            "studyFirstPostDateStruct": {
                "date": "2023-02-24",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Bristol-Myers Squibb",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Ono Pharmaceutical Co. Ltd",
                    "class": "INDUSTRY"
                }
            ]
        },
        "descriptionModule": {
            "briefSummary": "The main purpose of this study is to identify important treatment attributes for post-radical cystectomy (RC) treatment for participants with MIBC (Muscle-Invasive Bladder Cancer) and assess the relative importance of treatment attributes for post-RC treatment in Japan."
        },
        "conditionsModule": {
            "conditions": [
                "Urinary Bladder Neoplasms"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 115,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1",
                    "description": "High-risk Muscle-Invasive Bladder Cancer (MIBC) participants following radical cystectomy"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Overall survival",
                    "description": "Median overall survival (years)",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                },
                {
                    "measure": "5-year survival rate",
                    "description": "Defined as the percentage of patients that are alive after 5 years",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                },
                {
                    "measure": "Disease-free survival (DFS)",
                    "description": "Median disease-free survival (year)",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                },
                {
                    "measure": "Probability of side effect-related treatment discontinuation",
                    "description": "Defined as the percent likelihood that a patient will stop treatment due to a side effect",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                },
                {
                    "measure": "Number of participants who experience treatment side effects",
                    "description": "Defined as the percentage of participants who experience nausea, diarrhea, fatigue, skin-related side effects (e.g. pruritus, rash), endocrine system-related side effects (e.g. hypothyroidism), anemia, alopecia, reduced renal function, cardiac impairment, leukopenia, neutropenia, and thrombocytopenia due to treatment",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                },
                {
                    "measure": "Overall severity of side effects",
                    "description": "Defined as the severity of side effects categorized as \"None\", \"mild-to-moderate\", or \"severe\"",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                },
                {
                    "measure": "Treatment Convenience",
                    "description": "Defined as the route of administration and frequency of administration per day or week (Infusions once every week, 2 weeks, or 4 weeks)",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                },
                {
                    "measure": "Treatment duration",
                    "description": "Defined as the total duration for continuous administration of treatment categorized as 2 months, 4 months, or 1 year",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                },
                {
                    "measure": "Hospitalization",
                    "description": "Defined as the length of hospitalization required for administration of treatment categorized as 0 days (no hospitalization required for administration of treatment), 1 week, or more than 1 week",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                },
                {
                    "measure": "Frequency of outpatient consultations",
                    "description": "Defined as the number of outpatient consultations required for treatment administration and monitoring categorized as every 2 weeks, 4 weeks, or 3 months",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                },
                {
                    "measure": "Annual treatment costs",
                    "description": "Defined as the annual out-of-pocket treatment costs, categorized as 10,000, 300,000, or 650,000 JPY",
                    "timeFrame": "Up to 1 year after radical cystectomy"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Must reside in Japan and able to speak/read Japanese for the interview/survey\n* Must have a clinical diagnosis of Muscle-invasive bladder cancer (MIBC):\n\n  * ypT2-ypT4a or ypN+ MIBC, with prior neoadjuvant cisplatin chemotherapy and underwent radical cystectomy\n  * pT3-pT4a or pN+ MIBC, without prior neoadjuvant cisplatin chemotherapy and underwent radical cystectomy\n* Must not have received any treatment related to MIBC after radical cystectomy\n\nExclusion Criteria:\n\n* Determined by the physician as being unsuitable for the study (e.g. having any clinically significant psychiatric disorder, cognitive impairment, or having difficulty with communicating in Japanese)\n* Confirmed diagnosis of other primary cancers at the time of obtaining consent\n* Current participation in a MIBC clinical trial",
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "The study population is composed of 115 Japanese participants, 18 years and older, with muscle-invasive urothelial carcinoma of the bladder following radical cystectomy.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BMS Study Connect Contact Center http://www.bmsstudyconnect.com",
                    "role": "CONTACT",
                    "phone": "855-907-3286",
                    "email": "Clinical.Trials@bms.com"
                },
                {
                    "name": "First line of the email MUST contain NCT # and Site #.",
                    "role": "CONTACT"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Bristol-Myers Squibb",
                    "affiliation": "Bristol-Myers Squibb",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Local Institution - 0001",
                    "status": "RECRUITING",
                    "city": "Morrisville",
                    "state": "North Carolina",
                    "zip": "27560",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site 0001",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.82348,
                        "lon": -78.82556
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "BMS Clinical Trial Information",
                    "url": "https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html"
                },
                {
                    "label": "Investigator Inquiry Form",
                    "url": "https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html"
                },
                {
                    "label": "FDA Safety Alerts and Recalls",
                    "url": "https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"
                },
                {
                    "label": "BMS Clinical Trial Patient Recruiting",
                    "url": "https://www.bmsstudyconnect.com/s/US/English/USenHome"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002295",
                    "term": "Carcinoma, Transitional Cell"
                },
                {
                    "id": "D000001749",
                    "term": "Urinary Bladder Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000001745",
                    "term": "Urinary Bladder Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5030",
                    "name": "Urinary Bladder Neoplasms",
                    "asFound": "Urinary Bladder Neoplasms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5551",
                    "name": "Carcinoma, Transitional Cell",
                    "asFound": "Urothelial Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M5026",
                    "name": "Urinary Bladder Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5693",
                    "name": "Transitional Cell Carcinoma",
                    "asFound": "Urothelial Carcinoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}